newsfilter
← Latest News
GlobeNewswire·

Chinook Therapeutics to Present at Upcoming Investor Conferences

SEATTLE, Sept. 01, 2022 (GLOBE NEWSWIRE) -- Chinook Therapeutics, Inc. (NASDAQ:KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook manag